Robert Barrow - 24 Mar 2004 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MNMD
Reported as of: 24 Mar 2004
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Mar 2022, 20:03:28 UTC
Next SEC filing: 10 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Robert Barrow

Key filing fact

Robert Barrow filed Form 4 for Mind Medicine (MindMed) Inc. (MNMD) on 28 Mar 2022.

Key facts

This page summarizes Robert Barrow's Form 4 filing for Mind Medicine (MindMed) Inc. (MNMD).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 28 Mar 2022, 20:03.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MNMD transaction

Subordinate Voting Shares

Award

Transaction value: $0
Shares: +1,820,000
Change %: +82%
Price: $0.000000
Shares after: 4,033,367
Date: 24 Mar 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNMD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +2,910,000
Change %: +83%
Price: $0.000000
Shares after: 6,425,500
Date: 24 Mar 2022
Ownership: Direct
Underlying class: Subordinate Voting Shares
Underlying amount: 2,910,000
Exercise price: $1.18
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in 48 equal monthly installments beginning on April 24, 2022, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Footnote F2

The option grant has an exercise price of $1.48 Canadian Dollars. This represents the exercise price in United States Dollars.

Footnote F3

The shares subject to the option vest and become exercisable with 1/48th of the total shares vesting monthly over 48 months from the vesting commencement date, March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.